Anti-Obesity Prescription Drugs Market Production, Import, Export and Consumption Forecast & Regional Analysis by 2028


5 September 2019 - Global Anti-Obesity Prescription Drugs Market is expected to witness a staggering CAGR in the forecast period. Anti-obesity drugs are pharmacological agents that are used to drop cholesterol level and condense the body weight. These drugs are normally well-known for their action that can alter the important functioning of the normal body by utilizing the calories or by changing the appetite.

          

The growth of anti-obesity prescription drugs market is tremendously influenced because of the food consumptions and eating patterns of the masses has endured groundbreaking variations over the past decade. The liking of the youth for junk food has regulated in a higher incidence of obesity, which is increasing the demand for anti-obesity prescription drugs. There is a usage of cholesterol-rich products in the food items that are prepared in the restaurants, and this cooking method is now shifting to houses. This is playing a devious role in the progress of the anti-obesity prescription drug market in the existing development.

View Full Report with TOC @ https://www.millioninsights.com/industry-reports/anti-obesity-prescription-drugs-market

In addition to this, there is an upsurge in the level of chronic stress and rise in the consumption of alcoholic beverages will be continued by the consumers and this will expand the demand for anti-obesity prescription drugs. Also, there have been growing incidences of depression; which is leading to more intake of the psychotropic drugs and the side effects of these drugs leads to obesity. Looking at the ultramodern aspect, the existing as well new investors have started investing in this market, which will appeal the manufacturers and this will eventually lead to more effective anti-obesity prescription drugs. These are some of the major dynamics that will help the anti-obesity prescription drug market to experience massive growth during the forecast period.

The market is segmented on the basis of drug class (Bupropion and Naltrexone, Orlistat, Lorcaserin, Phentermine and Topiramate, Liraglutide); by age group (pediatric, adult); by end user (e-commerce, retail pharmacies, and hospital pharmacies) and by geography (North America, Europe, Latin America, Middle East & Africa, and Asia Pacific).

Geographically, North America is surging and holds the largest market share as the demand for weight loss/control drugs is increasing in this region is predicted to register an extensive growth rate during the estimated time span. Followed by this, Europe is anticipated to experience substantial growth prospects in the forthcoming years. Along with this, Asia Pacific is expected to foresee decent growth during the forecast period. In the near future, the market will continue to come up with some extraordinary product innovations to attract new consumers and investors, for them to continue the domination.

Some of the significant key players outlined in the anti-obesity prescription drugs market report are GlaxoSmithKline, VIVUS, Inc, F Hoffmann La Roche Ltd., Arena Pharmaceuticals, Inc., Alizyme, Orexigen Therapeutics, Inc., Boehringer Ingelheim and Novo Nordisk A/S. All the leading companies are including mergers and acquisitions, partnerships and joint ventures to enhance the growth of the market efficiently.

Market Segment:

Leading players of Anti-Obesity Prescription Drugs including:

• F Hoffmann La Roche
• Arena Pharmaceuticals
• Orexigen Therapeutics
• Phentermine and Topiramate
• VIVUS, Inc
• Liraglutide
• Bupropion and Naltrexone
• Orlistat
• Bupropion and Naltrexone
• Novo Nordisk
• Lorcaserin

Market split by Type, can be divided into:

• Oral Medicine
• Diet Patch
• Other

Market split by Application, can be divided into:

• Hospitals Pharmacies
• Retail Pharmacies
• E-commerce

Request Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/anti-obesity-prescription-drugs-market/request-sample


Location: Ludwig-Jahn-Straße 15, 91257 Pegnitz, Germany

Comments

Post a Comment

Popular posts from this blog

Thermal Interface Materials Market Revenue, Share and Growth Rate to 2030

  The global thermal interface materials (TIMs) market size was estimated at USD 4.10 billion in 2024 and is projected to reach USD 7.89 billion by 2030, registering a strong CAGR of 11.6% from 2025 to 2030. Growth in this market is primarily driven by the increasing adoption of consumer electronics such as smartphones, laptops, gaming systems, and wearable devices, which require efficient heat dissipation to maintain performance. Similarly, the rising use of industrial automation technologies in developing economies, combined with the growing disposable income of the middle-class population, is significantly boosting demand for TIMs. These materials are specifically engineered to be applied between two hard surfaces often between electronic components and heat sinks to facilitate efficient heat conduction, ensuring safe operation even as devices become smaller, faster, and more powerful. The diverse commercial availability of TIMs in multiple formats, including grea...
Read more

Advancing Hydrogen Production Through Next Generation Electrolyzer Technologies

  Electrolyzers are at the center of the global transition toward clean energy and decarbonization. By using electricity to split water into hydrogen and oxygen, electrolyzers enable the production of green hydrogen when powered by renewable sources such as solar and wind. As governments and industries seek alternatives to fossil fuels, electrolyzer technology is rapidly evolving to deliver higher efficiency, scalability, and cost effectiveness. Hydrogen produced through electrolysis offers significant potential for decarbonizing hard to abate sectors including heavy industry, transportation, and power generation. Unlike conventional hydrogen production methods that rely on natural gas reforming, electrolyzers provide a pathway to low carbon hydrogen, supporting climate goals and long term energy security. Technology Advancement Across Electrolyzer Several electrolyzer technologies are currently shaping the industry, each offering distinct advantages. Alkaline electrol...
Read more

Drug Discovery Outsourcing Driving Faster Innovation and Smarter R&D Strategies

  Drug discovery outsourcing has emerged as a strategic approach for pharmaceutical and biotechnology companies seeking to enhance efficiency, reduce costs, and accelerate innovation. As therapeutic research becomes increasingly complex, organizations are turning to specialized external partners to manage critical aspects of the discovery pipeline. By leveraging advanced technologies, global expertise, and scalable infrastructure, outsourcing has become a cornerstone of modern drug development strategies. The early stages of drug development require significant investment in target identification, lead optimization, preclinical testing, and regulatory documentation. Managing these processes internally can strain resources and extend development timelines. Drug discovery outsourcing allows companies to access experienced scientific teams, state of the art laboratories, and advanced analytical tools without bearing the full burden of capital expenditure. Benefits of Out...
Read more